BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35535083)

  • 1. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.
    Singh S; Taneja S; Tandon P; Bansal A; Gorsi U; Roy A; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V
    J Clin Exp Hepatol; 2022; 12(2):398-408. PubMed ID: 35535083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.
    Tandon P; Tangri N; Thomas L; Zenith L; Shaikh T; Carbonneau M; Ma M; Bailey RJ; Jayakumar S; Burak KW; Abraldes JG; Brisebois A; Ferguson T; Majumdar SR
    Am J Gastroenterol; 2016 Dec; 111(12):1759-1767. PubMed ID: 27481305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease.
    Skladany L; Drotarova Z; Vnencakova J; Jancekova D; Molcan P; Koller T
    Croat Med J; 2021 Feb; 62(1):8-16. PubMed ID: 33660956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis.
    Siramolpiwat S; Kiattikunrat K; Soontararatpong R; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanun P; Issariyakulkarn N
    Scand J Gastroenterol; 2021 Oct; 56(10):1210-1219. PubMed ID: 34338110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty is associated with increased risk of cirrhosis disease progression and death.
    Wang S; Whitlock R; Xu C; Taneja S; Singh S; Abraldes JG; Burak KW; Bailey RJ; Lai JC; Tandon P
    Hepatology; 2022 Mar; 75(3):600-609. PubMed ID: 34528267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 180-day mortality predictive score based on frailty syndrome in elderly patients with sepsis: a Logistic regression analysis model].
    Dong J; Wang L; Xiong R; Liu X; Guo Z; Sun W; Chen R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):257-262. PubMed ID: 33834964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
    Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.
    Lai JC; Rahimi RS; Verna EC; Kappus MR; Dunn MA; McAdams-DeMarco M; Haugen CE; Volk ML; Duarte-Rojo A; Ganger DR; O'Leary JG; Dodge JL; Ladner D; Segev DL
    Gastroenterology; 2019 May; 156(6):1675-1682. PubMed ID: 30668935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four different frailty models predict health outcomes in older patients with stable chronic obstructive pulmonary disease.
    Zhang D; Tang W; Dou LY; Luo J; Sun Y
    BMC Geriatr; 2022 Jan; 22(1):57. PubMed ID: 35034605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.
    Gupta T; Dhiman RK; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla Y
    J Clin Exp Hepatol; 2017 Mar; 7(1):9-15. PubMed ID: 28348465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis.
    Piotrowski D; Sączewska-Piotrowska A; Jaroszewicz J; Boroń-Kaczmarska A
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155772
    [No Abstract]   [Full Text] [Related]  

  • 15. The Range and Reproducibility of the Liver Frailty Index.
    Wang CW; Lebsack A; Chau S; Lai JC
    Liver Transpl; 2019 Jun; 25(6):841-847. PubMed ID: 30884128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis.
    Cullaro G; Verna EC; Duarte-Rojo A; Kappus MR; Ganger DR; Rahimi RS; Boyarsky B; Segev DL; McAdams-DeMarco M; Ladner DP; Volk ML; Hsu CY; Lai JC
    Hepatol Commun; 2022 Apr; 6(4):910-919. PubMed ID: 34676697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis.
    Essam Behiry M; Mogawer S; Yamany A; Rakha M; Awad R; Emad N; Abdelfatah Y
    Int J Hepatol; 2019; 2019():8092865. PubMed ID: 31186966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis.
    Kremer WM; Nagel M; Reuter M; Hilscher M; Michel M; Kaps L; Labenz J; Galle PR; Sprinzl MF; Wörns MA; Labenz C
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00211. PubMed ID: 32764204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.
    Dunn MA; Josbeno DA; Tevar AD; Rachakonda V; Ganesh SR; Schmotzer AR; Kallenborn EA; Behari J; Landsittel DP; DiMartini AF; Delitto A
    Am J Gastroenterol; 2016 Dec; 111(12):1768-1775. PubMed ID: 27575708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
    Hirota K; Kawaguchi T; Koya S; Nagamatsu A; Tomita M; Hashida R; Nakano D; Niizeki T; Matsuse H; Shiba N; Torimura T
    Hepatol Res; 2020 Mar; 50(3):330-341. PubMed ID: 31721387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.